Pharmacology
Sort by:
Cardiology Fiesta 2018
Results from the CABANA Trial: What Does it Mean
FEATURING
Douglas Packer
- 1,926 views
- November 28, 2018
- 10
Piedmont Heart Institute Napa Valley Cardiology Conference
Rate vs. Rhythm Control for Atrial Fibrillation
- 1,919 views
- February 9, 2018
- 9
Virtual EP Connect
AF Ablation as First-Line Therapy: Benefit vs Risk
FEATURING
Vivek Reddy,
Francis Marchlinski,
Jason Andrade,
Hugh Calkins,
Valentin Fuster,
Srinivas Dukkipati
- 1,909 views
- September 4, 2023
- 10
Cedars Sinai
Debate: Role of Digoxin in Heart Failure and Atrial Fibrillation - in Defense of Digoxin
FEATURING
John Mandrola
- 1,887 views
- February 8, 2022
- 15
Scottsdale Interventional Forum 2022
Top 5 Structural Trials of the Last Year: SIF 2022
FEATURING
Michael Reardon
- 1,862 views
- April 7, 2022
- 4
Cardiology Fiesta 2018
Heart Failure and Atrial Fibrillation – What Is the Right Approach for Your Patient?
FEATURING
Jayasree Pillarisetti
- 1,857 views
- November 28, 2018
- 12
American College of Cardiology
Voyager PAD Trial: How Effective Is Rivaroxaban for Patients with Lower Extremity PAD Undergoing Revascularization?
FEATURING
Peter Block,
Deepak Bhatt
- 1,852 views
- October 22, 2020
- 6
ACC 2023 Conference Coverage
ACC 2023: Is Rhythm Control Ever Good Enough?
FEATURING
Brian Olshansky
- 1,794 views
- March 7, 2023
- 13
Michigan Medicine
Coronary Artery Disease Risk Stratification: What Is the Current Status?
FEATURING
Vikas Aggarwal
- 1,772 views
- September 28, 2022
- 5
Scottsdale Interventional Forum 2015
PCI Pharmacology in 2015: Choosing the Right Antiplatelet & Anticoagulant Therapies
FEATURING
Steve Bailey
- 1,764 views
- May 9, 2015
- 6
Top Ten Topics in Clinical Cardiology 2021
Top 10 Clinical Trials in Coronary Interventions of 2020-2021
FEATURING
Samin Sharma
- 1,757 views
- November 2, 2021
- 8
Cardiovascular Disease Management: A Case-Based Approach 2018
Atrial Fibrillation: What Is the Best Approach to Treat and Control? A Practical Approach
FEATURING
Jared Bunch
- 1,725 views
- December 21, 2018
- 10
Mount Sinai Advanced Innovations in Heart Failure
Management of Atrial Fibrillation in Heart Failure: EAST-AFNET4, CABANA Trial and RAFT-AF Trials
FEATURING
Vivek Reddy
- 1,712 views
- March 2, 2022
- 9
Scottsdale Interventional Forum 2014
Essentials of ACS/PCI Pharmacology: An Overview and Approach
FEATURING
Robert Harrington
- 1,657 views
- March 20, 2014
- 5
California Heart Rhythm Symposium
Therapies for Atrial Fibrillation in the Next Decade
FEATURING
Hugh Calkins
- 1,642 views
- November 23, 2018
- 9
ARCH Advanced Revascularization Symposium
Highlights and Critiques of ACC/AHA/SCAI Revascularization Guidelines
FEATURING
David A. Cox
- 1,629 views
- June 2, 2022
- 14
Jonathan Piccini
Which Direct Acting Oral Anticoagulant for my Patient with Chronic Kidney Disease?
- 1,479 views
- October 4, 2018
- 12
Complex Coronary Cases
Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Use Triple Therapy?
FEATURING
Usman Baber
- 1,432 views
- August 13, 2020
- 17